# FDA Approves Vanda Pharmaceuticals' New Drug Application The FDA has approved NDA 220358 for Vanda Pharmaceuticals Inc., potentially expanding the company's product portfolio and positioning it to capture additional market share in its therapeutic area. The approval could drive near-term revenue growth for Vanda and strengthen its competitive standing as the company works to diversify its commercial offerings beyond its existing marketed products.